These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5123842)

  • 41. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
    Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Association of scarlet fever with vaccination against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():105-6. PubMed ID: 14349283
    [No Abstract]   [Full Text] [Related]  

  • 43. [Serologic reactions in vaccinated and not vaccinated subjects against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Apr; 4():67-70. PubMed ID: 14387224
    [No Abstract]   [Full Text] [Related]  

  • 44. [Investigations on living vaccine against tularemia. I. Mildly pathogenic of Bacterium tularense and their immunologic properties].
    SKRODZKI E; TOMASZUNAS S
    Przegl Epidemiol; 1955; 9(3):199-210. PubMed ID: 13310637
    [No Abstract]   [Full Text] [Related]  

  • 45. Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.
    De Pascalis R; Mittereder L; Chou AY; Kennett NJ; Elkins KL
    PLoS One; 2015; 10(5):e0126570. PubMed ID: 25973794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    O'Malley KJ; Bowling JD; Stinson E; Cole KS; Mann BJ; Namjoshi P; Hazlett KRO; Barry EM; Reed DS
    PLoS One; 2018; 13(10):e0205928. PubMed ID: 30346998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Determination of tularemia antibodies by an immunoenzyme method on a solid-phase carrier (ELISA)].
    Umnova NS; Shakhanina KL; Meshcheriakova IS; Pavlova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):79-83. PubMed ID: 6377770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of immunobiological activity of Francisella tularensis C-complex preparations as promising component of subunit vaccines].
    Volokh OA; Shepelev IA; Firsova VV; Khramkova EM; Avdeeva NG; Samokhvalova IuI; Eremin SA; Diatlov IA; Zhemchugov VE
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):16-21. PubMed ID: 17672125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Special preventive immunization against early summer meningoencephalitis and tularemia for laborers of the Natural Gas Central Youth Project in the USSR].
    Gille H; Hölzer E; Stehle P; Steinrück M
    Z Arztl Fortbild (Jena); 1990; 84(8):391-2. PubMed ID: 2165713
    [No Abstract]   [Full Text] [Related]  

  • 53. Aerogenic immunization of man with live Tularemia vaccine.
    Hornick RB; Eigelsbach HT
    Bacteriol Rev; 1966 Sep; 30(3):532-8. PubMed ID: 5917334
    [No Abstract]   [Full Text] [Related]  

  • 54. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Case of allergic reaction to living tularemia vaccine].
    BELOSTOTSKAIA EN; MAKSIMOVA EB; MASHKILLEISON AL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jan; 1():97-8. PubMed ID: 14360676
    [No Abstract]   [Full Text] [Related]  

  • 56. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
    Onoprienko NN; Aronova NV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):22-9. PubMed ID: 27029112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent studies on live tularemia vaccine.
    Eigelsbach HT; Hornick RB; Tulis JJ
    Med Ann Dist Columbia; 1967 May; 36(5):282-6. PubMed ID: 4962955
    [No Abstract]   [Full Text] [Related]  

  • 58. COMPATIBILTIY OF STI ANTHRAX VACCINE WITH PLAGUE, TULAREMIA AND BRUCELLOSIS VACCINES.
    PILIPENKO VG; MIROSHNICHENKO MG
    Fed Proc Transl Suppl; 1964; 23():551-4. PubMed ID: 14185907
    [No Abstract]   [Full Text] [Related]  

  • 59. Tularemia: the disease and the weapon.
    Cronquist SD
    Dermatol Clin; 2004 Jul; 22(3):313-20, vi-vii. PubMed ID: 15207312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results and prospects of tularemia study and control in the USSR].
    Olsuf'ev NG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Dec; 49(12):29-35. PubMed ID: 4643650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.